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If we are to believe the Daily Mail,
US scientists have cloned the first
human embryo — and destroyed it.
This revelation came in the form
of a Daily Mail ‘exclusive’, which
appeared on 17 June. The headline
announced the “first cloned human
embryo,” and was accompanied by a
front-page picture of a “12-day-old
male human embryo consisting of
400 cells” that was reported to have
been incinerated two days after the
photograph had been taken. Its
creators were scientists at American
Cell Technology (ACT), a small
privately held biotech company in
Worcester, Massachusetts.
The story was picked up by the
tabloid press in Europe and
comparisons between ACT scientists
and God were plentiful. Witness, for
example, the 18 June headline of
Bild Zeitung, which has a readership
of 4 million Germans: “They’ve
really done it! They’ve taken
themselves for God!” Most of these
European newspapers were quite
unconcerned about repeating the
Daily Mail story without verification,
sometimes almost verbatim. The
picture, it seemed, was all the proof
that was needed to persuade the
editors of the story’s authenticity.
In France, however, the vast
majority of press accounts were
suprisingly more discerning in their
treatment of the story and the issues
surrounding cloning.
On 19 June, Libération, the
respected French left-wing daily,
revealed that the infamous
photograph was not of a cloned
human embryo but of a culture of
human embryonic stem cells.
Information for the Libération piece
came direct from the source — ACT.
Le Nouvel Observateur, which
described the Daily Mail story as a
“false alert” explained to its readers
that the photograph was “no closer to
the first cloned human embryo than
a piece of bark is to an entire tree.”
L’Express branded the Daily Mail
scoop a “coup de bluff” and wrote
that the “financial stakes of human
cloning are such that some will not
hesitate to fake a story.”
The successful isolation of stem
cells from aborted human fetuses
and from IVF-generated embryos
was reported last November in
Science and in the Proceedings of the
National Academy of Sciences USA by
two American teams — both funded
by Geron Corporation of Menlo
Park, California.
Even challenging technical details
got an airing in my local
newspaper, La Voix du Nord
Less than a week after the two
publications, ACT claimed to have
isolated embryonic stem cells from
human embryos cloned by injecting
human DNA into an enucleated cow
egg — the same nuclear transfer
technique that gave rise to Dolly the
sheep, the first mammal cloned from
an adult cell. The ACT work was
met with much scepticism as it was
not published in a scientific journal
(see Mediawatch, Curr Biol 1999,
9:R80), and was largely unreported
in Europe. This was the story that
was resurrected seven months later
as a Daily Mail exclusive, according
to Libération.
The spoof cloning story appeared
just seven days before the UK
government was due to announce its
decision on whether it would relax
the law to allow human cloning for
therapeutic purposes. It’s unlikely to
have influenced the outcome, yet the
government did reject the advice of
two of its own committees — which
recommended giving the go-ahead
— and set up a third advisory group
to think about the issues all over
again. This decision was widely
criticized in the UK press. “Feeble
and shortsighted”, was how the
Financial Times put it.
In France, where a 1994 law
banning human cloning is similarly
being reconsidered by the
government, most French
newspapers have devoted precious
column inches to explaining the
potential benefits of such research
and to pointing out that the aim is
not to clone an army of humans.
“The very large majority of scientists
are against reproductive cloning”
declared L'Express.
In case its readers should wonder
why any scientist in his or her right
mind would choose a cow embryo as
a vehicle for human DNA, Le Nouvel
Observateur offered the following
explanation: “[Because of] technical
limitations, hundreds of eggs are
needed to obtain a single embryo
suitable for producing a culture of
embryonic stem cells, and human
eggs are scarce.” Even seemingly
challenging technical details got an
airing in my local newspaper, La
Voix du Nord. It noted that cells
derived from such an embryo were
liable to be rejected on
transplantation as the cells would
still retain “a bit of [cow] genetic
material originating from the energy
factories — the mitochondria.”
Regardless of what the UK
government eventually decides, any
European ban on cloning seems
meaningless. As Le Nouvel
Observateur pointed out, the recent
acquisition by Geron Corporation of
Roslin Bio-Med — a company set up
to commercialize the cloning
expertise of the Roslin Institute in
Scotland, where Dolly the sheep was
created — means that cloned cells
and tissues could still make their way
to Europe legally, as long as the
initial cloning was done in the US,
where therapeutic cloning is allowed.
A conundrum, indeed, for the UK
government’s new advisory group.
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